jinrong Li

Dr. jinrong Li


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
MJMingyan Jiang
Mingyan Jiang
RHRuolan Hu
Ruolan Hu
RYRuixin Yu
Ruixin Yu
YTYiwei Tang
Yiwei Tang
JLjinrong Li
jinrong Li
A narrative review of mechanisms of ferroptosis in cancer: new challenges and opportunities Mingyan Jiang, Ruolan Hu, Ruixin Yu, Yiwei Tang, Jinrong Li

1 June 2021 in Translational Pediatrics
Verified
Journal Article
Open access
PDF file
MJMingyan Jiang
Mingyan Jiang
LYLianlian Yang
Lianlian Yang
JWJinhui Wu
Jinhui Wu
FXFei Xiong
Fei Xiong
JLjinrong Li
jinrong Li
Arboleda-Tham syndrome (OMIM#616268) is a newly named neurodevelopmental disorder, which is an autosomal dominant hereditary disease characterized by genetic variants. The clinical manifestations include global developmental delay, primary microcephaly, and craniofacial dysmorphism, as well as more varied features such as feeding difficulties, cardiac defects, and ocular anomalies. Currently, due to restricted knowledge of Arboleda-Tham syndrome and less specific pathological manifestations, it is difficult to diagnose at the early stages of the disease. Here, we present a case with obvious growth retardation and intellectual disability, accompanied by other manifestations including dysmorphic features of the ears, facial dysmorphism, right cryptorchidism, and inguinal hernia. Routine laboratory tests including blood-urine tandem mass spectrometry, urine gas chromatographic mass spectrometry, karyotype, echocardiography, automatic auditory brainstem responses, serum levels of calcium, phosphorus, vitamin D, creatine kinase (CK), and CK isoenzyme (CK-MB), and brain magnetic resonance imaging showed negative results. A de novo heterozygous variant in KAT6A, c.57delA (p.Val20*), was detected by trio-based whole exome sequencing and subsequent validation by Sanger sequencing in the patient, which was absent in both the parents. The patient received rehabilitation and nutritional intervention. The testis reduction and orchiopexy was scheduled when he was 1 year old. Our report extends the phenotype-genotype map of Arboleda-Tham syndrome, and also expands the mutant spectrum of the KAT6A gene. Moreover, this case emphasizes the timely conduction of whole exome sequencing for the early diagnosis of Arboleda-Tham syndrome, and spares patients from meaningless examinations and ineffective treatments.

1 November 2021
Verified
Journal Article
Closed access
LYLianlian Yang
Lianlian Yang
MJMingyan Jiang
Mingyan Jiang
RYRuixin Yu
Ruixin Yu
RHRuolan Hu
Ruolan Hu
FXFei Xiong
Fei Xiong
JLjinrong Li
jinrong Li

1 January 2021 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
MJMingyan Jiang
Mingyan Jiang
JWJialing Wang
Jialing Wang
RYRuixin Yu
Ruixin Yu
RHRuolan Hu
Ruolan Hu
JLjinrong Li
jinrong Li
A narrative review on the research progress of gonadal function protection in children with cancer Mingyan Jiang, Jialing Wang, Ruixin Yu, Ruolan Hu, Jinrong Li

22 June 2026 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
XFXiao Fu
Xiao Fu
LFLing Feng
Ling Feng
MJMingyan Jiang
Mingyan Jiang
JLjinrong Li
jinrong Li
Introduction: High heterogeneity characterizes the efficacy of omega-3 polyunsaturated fatty acid (PUFA) supplementation for attention-deficit/hyperactivity disorder (ADHD). This study aimed to examine whether baseline omega-3 nutritional status may partly explain variability in supplementation response. Methods: We conducted a PRISMA-compliant systematic review and meta-analysis registered in PROSPERO (CRD420251218861). PubMed, Embase, PsycINFO, and CENTRAL were searched from inception to December 2025. Eligible studies were randomized controlled trials (RCTs) of omega-3 supplementation in children and adolescents with ADHD that reported baseline nutritional biomarkers, such as erythrocyte EPA/DHA, and efficacy outcomes stratified or otherwise separable according to baseline biomarker status. Data were synthesized using random-effects meta-analysis of standardized mean differences (SMDs), with a prespecified categorical subgroup analysis comparing low-baseline versus normal/high or unstratified baseline estimates. Results: Seven RCTs, contributing 10 analytical estimates, were included. The overall pooled analysis showed a small statistically significant effect of omega-3 supplementation (SMD = 0.21, 95% CI: 0.04–0.38; p = 0.017), with moderate heterogeneity ( I 2 = 38.7%). Stratification by baseline biomarkers was associated with lower within-subgroup heterogeneity and suggested differential treatment effects by baseline status (χ 2 = 10.44, df = 1, p = 0.0012). The low-baseline subgroup (k = 4) showed a larger estimated effect (SMD = 0.52, 95% CI: 0.28–0.76; p < 0.001; I 2 = 0%), whereas the normal/high or unstratified baseline subgroup ( k = 6) did not show a statistically significant effect (SMD = 0.03, 95% CI: −0.15–0.21; p = 0.77; I 2 =). Discussion: Omega-3 supplementation response in pediatric ADHD may vary according to baseline nutritional status. However, the evidence base remains limited to seven RCTs, and definitions of low baseline status differed across trials according to biomarker matrix and study-specific thresholds. These findings should therefore be interpreted as preliminary and hypothesis-generating. Larger, prospectively stratified RCTs using harmonized biomarker assessments and standardized baseline cut-offs are needed before biomarker-guided omega-3 supplementation can be recommended for clinical nutritional guidance. Systematic review registration: PROSPERO https://www.crd.york.ac.uk/PROSPERO/view/CRD420251218861 , identifier CRD420251218861.

12 June 2025 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
JGJie Gao
Jie Gao
RWRuiqin Wang
Ruiqin Wang
ZPZhen Pan
Zhen Pan
RHRuolan Hu
Ruolan Hu
MJMingyan Jiang
Mingyan Jiang
JLjinrong Li
jinrong Li
The KBG syndrome (KBGS) affects several systems caused by the mutation of the ANKRD11 gene. The main manifestations of KGBS included hearing loss, feeding difficulties, craniofacial abnormalities, tooth deformity, and developmental delay (delayed overall development, convulsions, and intellectual abnormalities). Only 10%–26% of patients with KBG syndrome have congenital heart disease, including atrial and ventricular septal defects. Here, we report a case of KBG syndrome in a preterm newborn with low birth weight, a huge ventricular septal defect, and a congenital chylothorax. Whole-exome sequencing detected an ANKRD11 gene mutation in the infant. The finding expands the understanding of the clinical and genetic phenotype. The multidisciplinary consultation of the complex KGB syndrome including interventional occlusion, nutritional management, and rehabilitation training can improve the prognosis and outcome.